---
figid: PMC8068087__metabolites-11-00226-g001
figlink: pmc/articles/PMC8068087/figure/metabolites-11-00226-f001/
number: F1
caption: Three inhibitors (fidarestat, dehydroepiandrosterone (DHEA), and azaserine)
  were used to decrease glucose flux down glycolytic side branch pathways (polyol,
  PPP, and HBP, respectively). Fidarestat inhibits aldose reductase, an enzyme that
  catalyzes the first rate-limiting step of the polyol pathway and reduces glucose
  to sorbitol. DHEA inhibits glucose-6-phosphate dehydrogenase (G6PD), an enzyme involved
  in converting glucose-6P into 6P-glucolactone in the PPP. Azaserine inhibits the
  rate-limiting enzyme GFAT in the HBP, a pathway responsible for producing UDP-GlcNAc.
  See  for metabolite abbreviations.
pmcid: PMC8068087
papertitle: 13C Metabolic Flux Analysis Indicates Endothelial Cells Attenuate Metabolic
  Perturbations by Modulating TCA Activity.
reftext: Bilal Moiz, et al. Metabolites. 2021 Apr;11(4):226.
pmc_ranked_result_index: '49900'
pathway_score: 0.9463175
filename: metabolites-11-00226-g001.jpg
figtitle: Three inhibitors (fidarestat, dehydroepiandrosterone (DHEA), and azaserine)
  were used to decrease glucose flux down glycolytic side branch pathways (polyol,
  PPP, and HBP, respectively)
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8068087__metabolites-11-00226-g001.html
  '@type': Dataset
  description: Three inhibitors (fidarestat, dehydroepiandrosterone (DHEA), and azaserine)
    were used to decrease glucose flux down glycolytic side branch pathways (polyol,
    PPP, and HBP, respectively). Fidarestat inhibits aldose reductase, an enzyme that
    catalyzes the first rate-limiting step of the polyol pathway and reduces glucose
    to sorbitol. DHEA inhibits glucose-6-phosphate dehydrogenase (G6PD), an enzyme
    involved in converting glucose-6P into 6P-glucolactone in the PPP. Azaserine inhibits
    the rate-limiting enzyme GFAT in the HBP, a pathway responsible for producing
    UDP-GlcNAc. See  for metabolite abbreviations.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAL
  - CIT
  - NADP
  - DHEA
  - NADH
  - NAD
  - NADPH
  - Polyol
  - Ribulose-5-P
  - DHAP
  - Gln
  - Glu
  - UDP
genes:
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: Cit
  symbol: CIT
  source: hgnc_symbol
  hgnc_symbol: CIT
  entrez: '11113'
chemicals:
- word: NADP
  source: MESH
  identifier: D009249
- word: DHEA
  source: MESH
  identifier: D003687
- word: NADH
  source: MESH
  identifier: D009243
- word: NAD
  source: MESH
  identifier: D009243
- word: NADPH
  source: MESH
  identifier: D009249
- word: Polyol
  source: MESH
  identifier: C029873
- word: Ribulose-5-P
  source: MESH
  identifier: C100182
- word: DHAP
  source: MESH
  identifier: C017202
- word: Gln
  source: MESH
  identifier: C544323
- word: Glu
  source: MESH
  identifier: C094686
- word: UDP
  source: MESH
  identifier: D014530
diseases: []
figid_alias: PMC8068087__F1
redirect_from: /figures/PMC8068087__F1
figtype: Figure
---
